TD Asset Management Inc. Has $74.67 Million Stake in Stryker Corporation (SYK)

TD Asset Management Inc. increased its position in shares of Stryker Corporation (NYSE:SYK) by 4.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 525,754 shares of the medical technology company’s stock after buying an additional 24,542 shares during the quarter. TD Asset Management Inc. owned about 0.14% of Stryker worth $74,668,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Coldstream Capital Management Inc. raised its position in shares of Stryker by 3.7% during the 2nd quarter. Coldstream Capital Management Inc. now owns 17,445 shares of the medical technology company’s stock valued at $2,421,000 after buying an additional 626 shares during the period. Retirement Systems of Alabama raised its position in shares of Stryker by 2.5% during the 3rd quarter. Retirement Systems of Alabama now owns 234,870 shares of the medical technology company’s stock valued at $33,356,000 after buying an additional 5,656 shares during the period. Lockheed Martin Investment Management Co. purchased a new stake in shares of Stryker during the 2nd quarter valued at approximately $1,249,000. Toronto Dominion Bank raised its position in shares of Stryker by 25.8% during the 2nd quarter. Toronto Dominion Bank now owns 105,403 shares of the medical technology company’s stock valued at $14,625,000 after buying an additional 21,585 shares during the period. Finally, Colonial Trust Advisors raised its position in Stryker by 56.1% in the second quarter. Colonial Trust Advisors now owns 23,446 shares of the medical technology company’s stock valued at $3,254,000 after purchasing an additional 8,426 shares during the period. 74.20% of the stock is currently owned by hedge funds and other institutional investors.

SYK has been the topic of a number of research analyst reports. Cowen Inc reissued a “buy” rating and issued a $160.00 target price (up previously from $150.00) on shares of Stryker in a research report on Sunday, July 30th. BidaskClub lowered Stryker from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Zacks Investment Research raised Stryker from a “hold” rating to a “buy” rating and set a $166.00 target price on the stock in a research report on Tuesday, August 1st. Oppenheimer Holdings, Inc. reissued a “hold” rating on shares of Stryker in a research report on Wednesday, August 23rd. Finally, Canaccord Genuity reissued a “buy” rating and issued a $155.00 target price (down previously from $158.00) on shares of Stryker in a research report on Thursday, August 24th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $152.10.

Stryker Corporation (NYSE SYK) traded down $0.15 during trading hours on Friday, hitting $154.67. 581,130 shares of the company’s stock traded hands, compared to its average volume of 1,157,184. The firm has a market capitalization of $57,883.39, a P/E ratio of 24.51, a price-to-earnings-growth ratio of 2.44 and a beta of 0.79. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. Stryker Corporation has a fifty-two week low of $110.00 and a fifty-two week high of $160.62.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.50 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.97 billion. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The company’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.39 earnings per share. research analysts expect that Stryker Corporation will post 6.47 earnings per share for the current fiscal year.

In other Stryker news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the transaction, the insider now owns 83,207 shares in the company, valued at $12,925,375.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 7.40% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://transcriptdaily.com/2017/11/26/td-asset-management-inc-has-74-67-million-stake-in-stryker-corporation-syk.html.

Stryker Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply